EGFR and head and neck squamous cell carcinoma: Stratification of patients from the Cancer Genome Atlas (TCGA) HNSCC cohort [9], using reversed-phase protein atlas data on EGFR expression, confirmed similar clinical outcome and poor OS of EGFRhigh patients, comparable with the LMU cohort (Fig 1B).